{"id":"https://openalex.org/W4387360633","doi":"https://doi.org/10.1210/jendso/bvad114.605","title":"FRI091 Treatment Of Secondary Hyperlipidemia Due To Nephrotic Syndrome","display_name":"FRI091 Treatment Of Secondary Hyperlipidemia Due To Nephrotic Syndrome","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387360633","doi":"https://doi.org/10.1210/jendso/bvad114.605"},"language":"en","primary_location":{"id":"doi:10.1210/jendso/bvad114.605","doi":"https://doi.org/10.1210/jendso/bvad114.605","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1210/jendso/bvad114.605","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1210/jendso/bvad114.605","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105003954","display_name":"Jeanette Girard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeanette Girard","raw_affiliation_strings":["Baylor College of Medicine , Houston, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Houston, TX , USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008103615","display_name":"Hamza Quadri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamza Quadri","raw_affiliation_strings":["Baylor College of Medicine , Pearland, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Pearland, TX , USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110600008","display_name":"Bryan C. Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan Jiang","raw_affiliation_strings":["Baylor College of Medicine , Bellaire, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Bellaire, TX , USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021651157","display_name":"Bahar Kapoor Force","orcid":"https://orcid.org/0000-0001-8843-4476","observed_orcids":["https://orcid.org/0000-0001-8843-4476"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bahar Kapoor Force","raw_affiliation_strings":["Baylor College of Medicine , Houston, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Houston, TX , USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064217820","display_name":"Layla A. Abushamat","orcid":"https://orcid.org/0000-0002-4074-881X","observed_orcids":["https://orcid.org/0000-0002-4074-881X"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Layla Abushamat","raw_affiliation_strings":["Baylor College of Medicine , Houston, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Houston, TX , USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056949921","display_name":"Rebecca Schneider Aguirre","orcid":"https://orcid.org/0000-0001-7279-9470","observed_orcids":["https://orcid.org/0000-0001-7279-9470"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Schneider Aguirre","raw_affiliation_strings":["Baylor College of Medicine , Houston, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine , Houston, TX , USA","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":{"value":3100,"currency":"USD","value_usd":3100},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24686111,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-hyperlipidemia","display_name":"secondary hyperlipidemia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8870000243186951},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.8600000143051147},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.7960000038146973},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.8339999914169312},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9120000004768372},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/ldl-receptor","display_name":"LDL receptor","score":0.5899999737739563},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.4020000100135803},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7239999771118164},{"id":"https://openalex.org/keywords/dyslipidemia-management","display_name":"dyslipidemia management","score":0.6439999938011169},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.41499999165534973},{"id":"https://openalex.org/keywords/atherogenic-lipoproteins","display_name":"atherogenic lipoproteins","score":0.7390000224113464},{"id":"https://openalex.org/keywords/hmg-coa-reductase","display_name":"HMG-CoA reductase","score":0.7639999985694885},{"id":"https://openalex.org/keywords/lipoprotein-lipase","display_name":"lipoprotein lipase","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C2778930706","wikidata":"https://www.wikidata.org/wiki/Q504790","display_name":"Nephrotic syndrome","level":2,"score":0.796743631362915},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.767391562461853},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.738471269607544},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6879922151565552},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5327638983726501},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.52080237865448},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3987548351287842},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.11231398582458496}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1210/jendso/bvad114.605","doi":"https://doi.org/10.1210/jendso/bvad114.605","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1210/jendso/bvad114.605","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10554725","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10554725","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10554725/pdf/bvad114.605.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Endocr Soc","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1210/jendso/bvad114.605","doi":"https://doi.org/10.1210/jendso/bvad114.605","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1210/jendso/bvad114.605","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387360633.pdf","grobid_xml":"https://content.openalex.org/works/W4387360633.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4229006574","https://openalex.org/W3160591423","https://openalex.org/W4410849986","https://openalex.org/W3092204742","https://openalex.org/W4255983447","https://openalex.org/W2050430788","https://openalex.org/W3041130907","https://openalex.org/W1856836055","https://openalex.org/W2489900224","https://openalex.org/W2414599353"],"abstract_inverted_index":{"Abstract":[0],"Disclosure:":[1],"J.":[2],"Girard:":[3],"None.":[4,7,10,13,16,19],"H.":[5],"Quadri:":[6],"B.":[8],"Jiang:":[9],"B.K.":[11],"Force:":[12],"L.":[14],"Abushamat:":[15],"R.S.":[17],"Aguirre:":[18],"Introduction:":[20],"Secondary":[21],"Hyperlipidemia":[22],"associated":[23,91,134],"with":[24,108,135,146,157,243,321],"nephrotic":[25,71,83,136,311,341],"syndrome":[26,72,84,137,312],"contributes":[27],"to":[28,68,74,97,153,257,266,279,299],"significant":[29,148],"cardiovascular":[30,105,174],"morbidity.":[31],"The":[32,237,263],"elevated":[33,121,307],"atherogenic":[34,98],"lipoprotein":[35,47],"levels":[36,309],"are":[37,112,116],"caused":[38],"by":[39],"upregulation":[40],"of":[41,46,60,104,132,159,172,186,290,319],"HMG-CoA":[42],"reductase":[43],"and":[44,57,138,161,169,203,216,232,250,323,328],"downregulation":[45],"lipase.":[48],"More":[49],"recently,":[50],"studies":[51],"in":[52,70,77,101,314],"mice":[53],"have":[54,267],"linked":[55],"PCSK9":[56,114,281,329,350],"Inducible":[58],"Degrader":[59],"the":[61,75,86,90,102,154],"LDL":[62,78,119,190,255,286,308,320,358],"Receptor":[63],"(IDOL)":[64],"as":[65],"primary":[66],"contributors":[67],"hypercholesterolemia":[69,133],"due":[73],"decrease":[76],"receptor":[79],"recycling":[80],"(1).":[81],"Treating":[82],"is":[85],"first-line":[87],"treatment":[88,139,241,283,289],"for":[89,284],"secondary":[92,338],"hyperlipidemia.":[93],"Since":[94],"exposure":[95],"time":[96],"lipoproteins":[99],"matters":[100],"development":[103],"disease,":[106],"statins,":[107],"or":[109],"without":[110],"ezetimibe,":[111],"utilized.":[113],"inhibitors":[115],"initiated":[117],"if":[118],"remains":[120],"despite":[122],"these":[123],"measures.":[124],"This":[125,302],"case":[126,131,303],"report":[127],"highlights":[128],"a":[129,167,179,228,315],"severe":[130],"response.":[140],"Clinical":[141],"Case:":[142],"A":[143,224],"55-year-old":[144],"male":[145],"no":[147],"past":[149],"medical":[150],"history":[151,171],"presented":[152],"emergency":[155],"department":[156],"shortness":[158],"breath":[160],"lower":[162],"extremity":[163],"edema.":[164],"He":[165],"denied":[166],"family":[168],"personal":[170],"premature":[173],"disease.":[175],"Initial":[176],"evaluation":[177],"revealed":[178,227],"serum":[180,208],"total":[181],"cholesterol":[182],"on":[183],"10x":[184],"dilution":[185],"833.9":[187],"(</=200mg/dL),":[188],"calculated":[189,218],"718mg/dL":[191],"(<100mg/dL),":[192],"triglycerides":[193],"381mg/dL":[194],"(<150mg/dL),":[195],"HDL":[196],"39.3mg/dL":[197],"(40-60mg/dL),":[198],"Apo":[199],"B":[200],">400mg/dL":[201],"(<90mg/dL),":[202],"Lp(a)":[204],"17.5mg/dL":[205],"(<75mg/dL).":[206],"His":[207,254],"albumin":[209,269],"was":[210],"<1.5g/dL":[211],"(4.2-4.5g/dL),":[212],"creatinine":[213],"2mg/dL":[214],"(0.7-1.3mg/dL),":[215],"24-hour":[217],"urinary":[219],"protein":[220],"level":[221],"10,294mg/24-hour":[222],"(30-150mg/24-hour).":[223],"kidney":[225,271],"biopsy":[226],"mixed":[229],"Type":[230,233],"III":[231],"V":[234],"Lupus":[235],"Nephritis.":[236],"patient":[238,264,293],"started":[239],"lupus":[240],"along":[242],"atorvastatin":[244],"80mg":[245],"qHS,":[246],"fenofibrate":[247],"45mg":[248],"daily,":[249],"ezetimibe":[251,324,327],"10mg":[252],"daily.":[253],"decreased":[256],"418mg/dL":[258],"(<100mg/dL)":[259],"after":[260,274],"15":[261],"days.":[262],"continued":[265],"undetectable":[268],"although":[270],"function":[272],"improved":[273],"2":[275],"months.":[276],"We":[277],"planned":[278],"initiate":[280],"inhibitor":[282,330],"further":[285],"reduction":[287,318],"pending":[288],"lupus,":[291],"but":[292],"died":[294],"from":[295,310,340],"septic":[296],"shock":[297],"prior":[298],"initiation.":[300],"Conclusion:":[301],"illustrates":[304],"that":[305],"extremely":[306],"resulted":[313],"nearly":[316],"60%":[317],"statin":[322],"treatment.":[325],"Statins,":[326],"therapy":[331],"should":[332],"be":[333],"considered":[334],"stepwise":[335],"when":[336],"treating":[337],"hyperlipidemia":[339],"syndrome.":[342],"1.":[343],"LIU":[344],"S,":[345],"VAZIRI":[346],"ND.":[347],"ROLE":[348],"OF":[349,356],"AND":[351,361],"IDOL":[352],"IN":[353,363],"THE":[354],"PATHOGENESIS":[355],"ACQUIRED":[357],"RECEPTOR":[359],"DEFICIENCY":[360],"HYPERCHOLESTEROLEMIA":[362],"NEPHROTIC":[364],"SYNDROME.":[365],"NEPHROL":[366],"DIAL":[367],"TRANSPLANT.":[368],"2014":[369],"MAR;29(3):538-43.":[370],"DOI:":[371],"10.1093/NDT/GFT439.":[372],"EPUB":[373],"2013":[374],"OCT":[375],"28.":[376],"PMID:":[377],"24166456":[378],"Presentation:":[379],"Friday,":[380],"June":[381],"16,":[382],"2023":[383]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-06T00:00:00"}